Literature DB >> 22518862

Validation of increased blood storage times with the T-SPOT.TB assay with T-Cell Xtend reagent in individuals with different tuberculosis risk factors.

Shu-Hua Wang1, Samuel S Stew, Joshua Cyktor, Bridget Carruthers, Joanne Turner, Blanca I Restrepo.   

Abstract

We compared the performance of the T-SPOT.TB assay with blood used within 0 to 3.5 h after collection (control) to its performance with blood stored for 0 to 3.5, 5 to 8, 18 to 21, or 31 to 33 h with the addition of T-Cell Xtend (experimental), using samples from 154 participants. The 95.4% concordance between paired specimens indicated that blood can be stored for up to 33 h prior to T-SPOT.TB testing.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22518862      PMCID： PMC3405595          DOI： 10.1128/JCM.00674-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay.

Authors:  Victor Herrera; Ellen Yeh; Kelly Murphy; Julie Parsonnet; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

2.  Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice.

Authors:  T Meier; H-P Eulenbruch; P Wrighton-Smith; G Enders; T Regnath
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

3.  Standardization and validation issues of the ELISPOT assay.

Authors:  Sylvia Janetzki; Josephine H Cox; Neal Oden; Guido Ferrari
Journal:  Methods Mol Biol       Date:  2005

4.  Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection.

Authors:  David Doberne; Rajiv L Gaur; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

5.  Comparison of same day versus delayed enumeration of TB-specific T cell responses.

Authors:  L M Lenders; R Meldau; R N van Zyl-Smit; V Woodburne; A Maredza; T J Cashmore; P L Semple; M Badri; A Zumla; K Dheda
Journal:  J Infect       Date:  2010-02-10       Impact factor: 6.072

6.  Improving the timeframe between blood collection and interferon gamma release assay using T-Cell Xtend®.

Authors:  J J M Bouwman; S F T Thijsen; A W Bossink
Journal:  J Infect       Date:  2011-11-18       Impact factor: 6.072

7.  Inhibition of activated/memory (CD45RO(+)) T cells by oxidative stress associated with block of NF-kappaB activation.

Authors:  K J Malmberg; V Arulampalam; F Ichihara; M Petersson; K Seki; T Andersson; R Lenkei; G Masucci; S Pettersson; R Kiessling
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

8.  Intra-assay reliability and robustness of QuantiFERON(R)-TB Gold In-Tube test in Zambia.

Authors:  K Shanaube; P De Haas; A Schaap; M Moyo; B Kosloff; A Devendra; E Raby; P Godfrey-Faussett; H Ayles
Journal:  Int J Tuberc Lung Dis       Date:  2010-07       Impact factor: 2.373

9.  Evaluation of a modified interferon-gamma release assay for the diagnosis of latent tuberculosis infection in adult and paediatric populations that enables delayed processing.

Authors:  Shu-Hua Wang; Dwight A Powell; Haikady N Nagaraja; Jessica D Morris; Larry S Schlesinger; Joanne Turner
Journal:  Scand J Infect Dis       Date:  2010-07-07

10.  Delayed processing of blood increases the frequency of activated CD11b+ CD15+ granulocytes which inhibit T cell function.

Authors:  Kyle C McKenna; Kelly M Beatty; Rodolfo Vicetti Miguel; Richard A Bilonick
Journal:  J Immunol Methods       Date:  2008-11-27       Impact factor: 2.303
View more
  8 in total

1.  Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection.

Authors:  Thara K Venkatappa; Rose Punnoose; Dolly J Katz; Michael P Higgins; Niaz Banaei; Edward A Graviss; Robert W Belknap; Christine S Ho
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

2.  The performance of T-cell Xtend reagent in increasing blood storage times for interferon gamma release assays.

Authors:  Junlian Li; Yan Liu; Liyamu Ma; Libike Gu; Quan Wang; Miao Xu; Ruiying Ma; Yali Zhang; Zhenping Yang; Junjie Deng; Xing Yi
Journal:  J Clin Lab Anal       Date:  2017-07-03       Impact factor: 2.352

Review 3.  Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?

Authors:  Niaz Banaei; Rajiv L Gaur; Madhukar Pai
Journal:  J Clin Microbiol       Date:  2016-01-13       Impact factor: 5.948

4.  Evaluation of risk factors for false-negative results with an antigen-specific peripheral blood-based quantitative T cell assay (T-SPOT®. TB) in the diagnosis of active tuberculosis: A large-scale retrospective study in China.

Authors:  Chi Yang; Shaojun Zhang; Lan Yao; Lin Fan
Journal:  J Int Med Res       Date:  2018-03-12       Impact factor: 1.671

5.  Boosting effect of IL-7 in interferon gamma release assays to diagnose Mycobacterium tuberculosis infection.

Authors:  Hellen Hiza; Lukas Fenner; Jerry Hella; Davis Kuchaka; Mohamed Sasamalo; Thomas Blauenfeldt; Gibson Kibiki; Reginald A Kavishe; Francis Mhimbira; Morten Ruhwald
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

6.  Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases-A Retrospective Survey From 2011 to 2019.

Authors:  Chi Yang; Xuejiao Luo; Lin Fan; Wei Sha; Heping Xiao; Haiyan Cui
Journal:  Front Cell Infect Microbiol       Date:  2021-02-18       Impact factor: 5.293

7.  Comparison of the Sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB According to Patient Age.

Authors:  Won Bae; Kyoung Un Park; Eun Young Song; Se Joong Kim; Yeon Joo Lee; Jong Sun Park; Young-Jae Cho; Ho Il Yoon; Jae-Joon Yim; Choon-Taek Lee; Jae Ho Lee
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

8.  Prospective comparison of two enzyme-linked immunosorbent spot assays for the diagnosis of Lyme neuroborreliosis.

Authors:  T van Gorkom; W Voet; S U C Sankatsing; C D M Nijhuis; E Ter Haak; K Kremer; S F T Thijsen
Journal:  Clin Exp Immunol       Date:  2020-01-07       Impact factor: 4.330
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.